Cargando…
Time to loss of response for dupilumab in ophiasis-pattern alopecia areata
Autores principales: | Choe, Sarah, Newman, Elan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413667/ https://www.ncbi.nlm.nih.gov/pubmed/34504923 http://dx.doi.org/10.1016/j.jdcr.2021.07.025 |
Ejemplares similares
-
Ophiasis Pattern Alopecia Areata in an Infant
por: Shakhashiro, Muna, et al.
Publicado: (2023) -
Ophiasis treated with dupilumab
por: Abercrombie, McKenna, et al.
Publicado: (2021) -
Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP)
por: Donovan, Jeff
Publicado: (2015) -
Resolution of dupilumab-associated alopecia areata with dosage modification
por: Kulkarni, Maansi, et al.
Publicado: (2022) -
Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
por: Cho, Sung Kyung, et al.
Publicado: (2021)